Position in UTHR
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$671,253
+$120,661 QoQ
Shares Held
1,132
+0.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Atria Investments, Inc holds $19,449,833 across 15 Drug Manufacturers - Specialty & Generic names. UTHR ranks #8 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
62,275 | $7,361,527 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
102,225 | $2,446,244 | |
| 3 | VTRS |
Viatris Inc
|
146,223 | $1,975,472 | |
| 4 | HLN |
Haleon plc
|
166,608 | $1,667,746 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
10,939 | $1,441,103 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
32,952 | $992,514 | |
| 7 | PBH |
Prestige Consumer Healthcare Inc.
|
14,395 | $853,191 | |
| 8 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
1,132 | $671,253 |
All Filings in UTHR
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $671,253 | 1,132 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $550,592 | 1,130 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $434,720 | 1,037 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $271,545 | 945 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $258,638 | 839 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $319,320 | 905 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $304,239 | 849 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $381,941 | 1,199 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||